Lineage Cell Therapeutics Inc at Solebury Trout KOL Day Transcript
Well, it looks like we can get started. So I'll introduce myself. I'm Brian Culley. I'm the Chief Executive Officer of Lineage Cell Therapeutics. We've got a fantastic day for you today. We've brought 2 individuals who are familiar with our work in the disease areas where we operate. I'll do their introductions in just a moment. After each presentation, there'll be some time for some Q&A. And then I'm just going to have a couple of slides just to get everybody oriented and underway.
We are a public company. I will refer you first to our safe harbor clause, in case I make any forward-looking statements.
So Lineage Cell Therapeutics, many of you, this will be a refresher, but we have 3 clinical stage programs, OpRegen, OPC1 and VAC2, 3 active clinical studies right now. These are supported by, I believe, one of the largest cell therapy intellectual property estates. We have north of 800 patents issued and applications pending. And what we do is we manufacture specific cell types. And then we transplant
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
